79 related articles for article (PubMed ID: 1824560)
21. Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials.
Mouridsen HT; Andersen AP; Brincker H; Dombernowsky P; Rose C; Andersen KW
NCI Monogr; 1986; (1):115-8. PubMed ID: 3534583
[TBL] [Abstract][Full Text] [Related]
22. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
25. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
26. [Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?].
Kroman NT; Jensen MB; Wohlfahrt J; Mouridsen H; Andersen PK; Melbye M
Ugeskr Laeger; 2000 May; 162(22):3184-8. PubMed ID: 10850209
[TBL] [Abstract][Full Text] [Related]
27. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)].
Axelsson CK; Andersen JA; Andersen KW; Blichert-Toft M; Dombernowsky P; Hansen M; Krag C; Mouridsen HT; Overgaard M; Rasmussen BB
Ugeskr Laeger; 1991 Aug; 153(33):2276-9. PubMed ID: 1781046
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
[TBL] [Abstract][Full Text] [Related]
30. Classical prognostic factors in node-negative breast cancer: the DBCG experience.
Mouridsen HT; Andersen J; Andersen KW; Axelsson C; Blichert-Toft M; Dombernowsky P; Hansen M; Krag C; Overgård M; Rasmussen BB
J Natl Cancer Inst Monogr; 1992; (11):163-6. PubMed ID: 1627423
[TBL] [Abstract][Full Text] [Related]
31. DBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients.
Ejlertsen B; Jensen MB; Mouridsen HT; Andersen J; Cold S; Jakobsen E; Kamby C; Sørensen PG; Ewertz M
Acta Oncol; 2008; 47(4):709-17. PubMed ID: 18465339
[TBL] [Abstract][Full Text] [Related]
32. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
33. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA
Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711
[TBL] [Abstract][Full Text] [Related]
34. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
Ejlertsen B; Mouridsen HT; Jensen MB; Bengtsson NO; Bergh J; Cold S; Edlund P; Ewertz M; de Graaf PW; Kamby C; Nielsen DL
J Clin Oncol; 2006 Nov; 24(31):4956-62. PubMed ID: 17075113
[TBL] [Abstract][Full Text] [Related]
35. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
36. [A randomized study of tumor resection versus mastectomy in breast cancer. 2. 6-year results of the DBCG-82TM (Danish Breast Cancer Cooperative Group) protocol].
Ugeskr Laeger; 1991 Aug; 153(33):2272-6. PubMed ID: 1781045
[TBL] [Abstract][Full Text] [Related]
37. The importance of surgery and accurate axillary staging for survival in breast cancer.
Grabau DA; Jensen MB; Blichert-Toft M; Andersen JA; Dyreborg U; Carstensen B; Al-Suliman NN; Graversen HP; Rose C
Eur J Surg Oncol; 1998 Dec; 24(6):499-507. PubMed ID: 9870724
[TBL] [Abstract][Full Text] [Related]
38. Treatment costs of adjuvant cytotoxic therapy in premenopausal breast cancer patients.
Løber J; Søgaard J; Mouridsen HT; Jørgensen J
Acta Oncol; 1988; 27(6A):767-71. PubMed ID: 3064779
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.
Mouridsen HT; Rose C; Overgaard M; Dombernowsky P; Panduro J; Thorpe S; Rasmussen BB; Blichert-Toft M; Andersen KW
Acta Oncol; 1988; 27(6A):699-705. PubMed ID: 3064775
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial.
Overgaard M; Christensen JJ; Johansen H; Nybo-Rasmussen A; Rose C; van der Kooy P; Panduro J; Laursen F; Kjaer M; Sørensen NE
Int J Radiat Oncol Biol Phys; 1990 Nov; 19(5):1121-4. PubMed ID: 2254100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
